With recent market volatility, Piper Sandler analysts believe investors should consider defensive growth stocks, highlighting the biopharmaceutical sector as a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE